Skip to main content
. Author manuscript; available in PMC: 2016 Apr 19.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Apr 4;21(7):1237–1245. doi: 10.1016/j.bbmt.2015.03.011

Table 2. Median Percentage Recipient Chimerism (Top) and ddCD3 Cell Counts (Bottom) by ATG Dosing Cohort and Time Post-SCT.

Time Post-SCT
1 mo 2 mo 3 mo 6 mo 9 mo 12 mo
ATG 7.5 6.7 8.8 18.5 8.7 .0 1.4
ATG 5.1 .0 1.0 1.5 .0 .0 .0
P on differences .20 .16 .024* .056 .052 .077
ATG 7.5 93.3 105.8 92.1 225.7 352.0 493.0
ATG 5.1 214.1 576.6 405.0 408.0 853.7 680.0
P on differences .068 .073 .031* .63 .071 .18
*

Statistically significant at P<.05.